quinazolines has been researched along with cholecystokinin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mason, NR; McCowan, JR; Mendelsohn, LG; Thrasher, KJ; Yu, MJ | 1 |
| Chiba, S; Haruta, K; Homma, N; Horiuchi, A; Iwatsuki, K; Yonekura, H | 1 |
| Chiba, S; Haruta, K; Homma, N; Iwatsuki, K; Yamagishi, F | 1 |
| Kökösi, A; Kovács, A; Orfi, L; Szabó, M | 1 |
| Kökösi, J; Orfi, L; Szabó, M | 1 |
| Czachura, JF; Rasmussen, K; Yu, MJ | 1 |
| Almási, J; Kökösi, J; Noszál, B; Takács-Novák, K | 1 |
| Almási, J; Kökösi, J; Takács-Novák, K; Vámos, J | 1 |
| Gergely, A; Gyimesi-Forrás, K; Kökösi, J; Szabó, M; Szász, G | 1 |
| Gupta, SP | 1 |
| Chang, FY; Hung, CR; Lin, LC; Pau, KY; Wang, PS; Wu, CL | 1 |
| Farook, JM; Lee, L; Moochhala, SM; Wang, Q; Wong, PT; Zhu, YZ | 1 |
| Djahanguiri, B; Massoudi, R; Rezayat, M; Roohbakhsh, A; Zarrindast, MR | 1 |
| Bertoglio, LJ; Zangrossi, H | 1 |
| Fang, YQ; Lautens, M; Yuen, J | 1 |
| Jensen, RT; Moody, TW; Nakamura, T; Nuche-Berenguer, B | 1 |
2 review(s) available for quinazolines and cholecystokinin
| Article | Year |
|---|---|
Quantitative structure-activity relationship studies on cholecystokinin antagonists.
Topics: Amino Acid Sequence; Amino Acids; Animals; Benzodiazepines; Cholecystokinin; Humans; Molecular Sequence Data; Peptides; Quantitative Structure-Activity Relationship; Quinazolines; Receptors, Cholecystokinin | 2002 |
EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer.
Topics: Antineoplastic Agents; Bombesin; Cell Proliferation; Cholecystokinin; Drug Synergism; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Neurotensin; Protein Kinase Inhibitors; Quinazolines; Receptors, G-Protein-Coupled | 2016 |
14 other study(ies) available for quinazolines and cholecystokinin
| Article | Year |
|---|---|
Quinazolinone cholecystokinin-B receptor ligands.
Topics: Animals; Brain; Cell Membrane; Cholecystokinin; Kinetics; Ligands; Mice; Molecular Structure; Quinazolines; Receptors, Cholecystokinin; Structure-Activity Relationship | 1991 |
Effects of DN-9693, a synthesized phosphodiesterase inhibitor, on pancreatic exocrine secretion in dogs.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Atropine; Cholecystokinin; Cimetidine; Dogs; Dose-Response Relationship, Drug; Female; Male; Pancreas; Pancreatic Juice; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Propranolol; Quinazolines; Secretin; Sulpiride; Theophylline | 1989 |
Effects of synthesized phosphodiesterase inhibitors, DM 9278 and HWA 285, on pancreatic exocrine secretion of the dog.
Topics: Animals; Atropine; Cholecystokinin; Dogs; Female; Male; Pancreas; Pancreatic Juice; Phosphodiesterase Inhibitors; Proteins; Quinazolines; Regional Blood Flow; Secretin; Sulpiride; Xanthines | 1985 |
[Synthesis of potential CCK antagonist quinazolone derivatives. II].
Topics: Cholecystokinin; Indicators and Reagents; Molecular Structure; Quinazolines; Structure-Activity Relationship | 1995 |
[Synthesis of potential CCK antagonist quinazolone derivatives].
Topics: Cholecystokinin; Magnetic Resonance Spectroscopy; Molecular Structure; Quinazolines; Spectrophotometry; Structure-Activity Relationship | 1995 |
Quinazolinone cholecystokinin (CCK)-B antagonists decrease midbrain dopamine unit activity.
Topics: Animals; Cholecystokinin; Electrophysiology; Indoles; Male; Mesencephalon; Neurons; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley | 1994 |
Characterization of potential NMDA and cholecystokinin antagonists I. acid-base properties of 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acids at the molecular and submolecular levels.
Topics: Cholecystokinin; Hydrogen-Ion Concentration; N-Methylaspartate; Quinazolines; Spectrophotometry, Ultraviolet | 1999 |
Characterization of potential NMDA and cholecystokinin antagonists. II. Lipophilicity studies on 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acid derivatives.
Topics: Cholecystokinin; Chromatography, Thin Layer; N-Methylaspartate; Quinazolines | 1999 |
Optical resolution of a series of potential cholecystokinin antagonist 4(3H)-quinazolone derivatives by chiral liquid chromatography on alpha1-acid glycoprotein stationary phase.
Topics: Cholecystokinin; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Orosomucoid; Quinazolines; Spectrophotometry, Ultraviolet; Stereoisomerism | 2000 |
Effects of evodiamine on gastrointestinal motility in male rats.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Gastric Emptying; Gastrointestinal Motility; Gastrointestinal Transit; Injections, Intraperitoneal; Male; Phenylurea Compounds; Plant Extracts; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 2002 |
Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodiazepines; Brain; Chemokines; Chemokines, CC; Cholecystokinin; Male; Maze Learning; Proglumide; Pyrazoles; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Species Specificity; Tetragastrin | 2004 |
Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety.
Topics: Animals; Anxiety; Bicuculline; Cholecystokinin; Dose-Response Relationship, Drug; GABA Antagonists; gamma-Aminobutyric Acid; Hippocampus; Male; Microinjections; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Stereotaxic Techniques | 2005 |
Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
Topics: Animals; Avoidance Learning; Behavior, Animal; Cholecystokinin; Disease Models, Animal; Exploratory Behavior; Fear; Male; Maze Learning; Motor Activity; Neural Pathways; Panic Disorder; Periaqueductal Gray; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Tetragastrin | 2005 |
CuI-Catalyzed tandem intramolecular amidation using gem-dibromovinyl systems.
Topics: Antifungal Agents; Benzodiazepinones; Catalysis; Cholecystokinin; Copper; Hydrocarbons, Brominated; Imidazoles; Indoles; Molecular Structure; Quinazolines; Vinyl Compounds | 2006 |